TG Therapeutics
TGTX
#2660
Rank
ยฃ4.09 B
Marketcap
ยฃ26.32
Share price
-0.43%
Change (1 day)
83.35%
Change (1 year)

Revenue for TG Therapeutics (TGTX)

Revenue in 2024 (TTM): ยฃ0.20 Billion

According to TG Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0.20 Billion. In 2023 the company made a revenue of ยฃ0.18 Billion an increase over the revenue in the year 2022 that were of ยฃ2.3 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TG Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.20 B12.06%
2023 ยฃ0.18 B7870.12%
2022 ยฃ2.3 M-53.56%
2021 ยฃ4.95 M4343.79%
2020 ยฃ0.11 M-3.8%
2019 ยฃ0.11 M-3.2%
2018 ยฃ0.11 M6.41%
2017 ยฃ0.11 M-8.87%
2016 ยฃ0.12 M20.1%
2015 ยฃ0.1 M5.06%
2014 ยฃ0.09 M5.95%
2013 ยฃ0.09 M683.87%
2012 ยฃ0.01 M
2011 N/A
2010 N/A
2009 N/A
2000 ยฃ3.59 M383.47%
1999 ยฃ0.74 M-61.41%
1998 ยฃ1.92 M953.77%
1997 ยฃ0.18 M4.24%
1996 ยฃ0.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ2.82 B 1,257.31%๐Ÿ‡ฎ๐Ÿ‡ณ India
ยฃ1.18 B 468.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland